AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.950
-0.490 (-9.01%)
Mar 13, 2026, 3:07 PM EDT - Market open
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $135.64 million as of March 13, 2026. Its market cap has increased by 301.74% in one year.
Market Cap
135.64M
Enterprise Value
79.20M
1-Year Change
301.74%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $135.64M, a decrease of -51.75%. That is a compound annual growth rate of -16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 149.07M | 377.19% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 162.66M |
| Tiziana Life Sciences | 160.81M |
| Rani Therapeutics Holdings | 156.76M |
| Connect Biopharma Holdings | 156.53M |
| Codexis | 154.45M |
| Unicycive Therapeutics | 150.65M |
| Sangamo Therapeutics | 147.22M |
| Spero Therapeutics | 145.92M |